Denavir OTC Switch Falters On Viral Resistance Questions
Executive Summary
Two FDA advisory committees unanimously disagreed on whether to recommend approval of the Rx-to-OTC switch of SmithKline Beecham's Denavir 1% penciclovir cream for cold sores on Dec. 1.
You may also be interested in...
GSK Valtrex Cold Sore Promotions Will Focus On One-Day, Oral Treatment
GlaxoSmithKline's Valtrex herpes labialis promotions will focus on the drug's convenience as an oral, one-day therapy following FDA's supplemental approval of the antiviral
GSK Valtrex Cold Sore Promotions Will Focus On One-Day, Oral Treatment
GlaxoSmithKline's Valtrex herpes labialis promotions will focus on the drug's convenience as an oral, one-day therapy following FDA's supplemental approval of the antiviral
SmithKline Denavir $10 Mil. DTC Television, Print Campaign Debuts July 12
SmithKline Beecham's Denavir (penciclovir) $10 mil. direct-to-consumer campaign will debut July 12.